West Nile Virus in the US: Annual Case Trends & Seasonal Patterns
West Nile Virus (WNV) is the leading cause of mosquito-borne disease in the continental US.
Epidemiology (CDC Data)
- Annual Cases: Highly variable; 2003 peak: 9,862; recent avg ~2,500 (neuroinvasive + non-neuroinvasive)
- Neuroinvasive Disease: ~1,000–1,500/yr (meningitis, encephalitis, AFP)
- Seasonality: June–September (peak August); rare winter cases in South
- Geography: Nationwide; highest incidence: Great Plains, Mountain West, California
Transmission Cycle
- Bird reservoir → Culex mosquito vector → human/horse (dead-end hosts)
- Rare: transfusion, transplant, mother-to-child, lab exposure
Clinical Spectrum
- Asymptomatic: 80%
- West Nile Fever: 20% (fever, headache, myalgia, rash, fatigue)
- Neuroinvasive: <1% (meningitis, encephalitis, acute flaccid paralysis)
Prevention
- EPA-registered repellents (DEET, picaridin, IR3535, OLE)
- Clothing: long sleeves, permethrin-treated
- Environmental: eliminate standing water, larvicides, community spraying
- No human vaccine; equine vaccine available
Surveillance
ArboNET: passive reporting of human, veterinary, mosquito, bird data. Guides public health response.
Viral Infections - Related Articles
- COVID-19 Pandemic Timeline: Key Events from December 2019 to December 2020
- Viruses and Illness: Can Viruses Get Sick?
- West Nile Virus: Viral or Bacterial? Symptoms, Transmission & Prevention
- Monkeypox Virus Replication: The Lytic Cycle
- Flu Symptoms, Treatment & Prevention: A Comprehensive Guide
- Fifth Disease in Adults: Symptoms, Risks & Complications
- Sucrose Gradient: Definition, Applications & Protein Purification
